Maintenance Treatment of Apatinib in Nasopharyngeal Carcinoma
NCT03130270
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
29
Enrollment
OTHER
Sponsor class
Conditions
Nasopharyngeal Carcinoma
Interventions
DRUG:
Apatinib mesylate tablet
Sponsor
Guilin Medical University, China
Collaborators
[object Object]
[object Object]
[object Object]